Video gives insight into the future of Cancer Prevention and Early Detection
Professor Gareth Evans, Cancer Prevention and Early Detection Lead, explains how our research will help to optimise screening and preventative strategies for common cancers, with a strong inherited component (breast cancer, colorectal cancer, endometrial cancer, ovarian cancer, prostate cancer and womb cancer).
This research is focused on helping to identify cancer risk sooner, match an individual to the preventive intervention (lifestyle changes and/or chemoprevention) most likely to work for them and, in some cases, may even help to prevent conditions progressing into cancer in the first place.
Research study testing new treatment for Sanfilippo disease progressing well
The study aims to establish whether Sanfilippo disease can be treated with a chemical found in soya beans.
Diagnosed in childhood, it is rare and fatal condition that affects around 150 children in the UK.
The study recruited 22 patients, with monitoring of the final patient due to finish in July. Results from the study will be published later this year.
You can read more about the new treatment for Sanfilippo disease on the CMFT Research & Innovation website.
£600K grant for congenital heart disease research
An early, success of the year-old DGEMBE genomic medicine collaboration, between Manchester and Cape Town universities, is the award of a £600K grant for combined work on congenital heart disease.
DGEMBE’s (Developing GEnomic Medicine BEtween Africa and the UK) principal aim is to develop a partnership between the two universities in rare disease research.
Leading the three-year initiative for The University of Manchester (UoM) are Professor Bernard Keavney, BHF Professor of Cardiovascular Medicine and Academic Lead for MAHSC Cardiovascular Domain, and Professor Graeme Black, Director of the Manchester Centre for Genomic Medicine.
Read more about the collaboration between Manchester and Cape Town universities on the MAHSC website.
1000th participant recruited for 100,000 genomes project
A lifelong patient of Saint Mary’s Hospital has become the 1000th participant in a ground-breaking project that is revolutionising the way those with rare genetic diseases are diagnosed and treated.
Ten year-old James Woods has joined the initiative which involves collecting and decoding 100,000 human genomes – complete sets of people’s genes – that will enable scientists and doctors to understand more about specific conditions.
The project has the potential to transform the future of healthcare. It could improve the prediction and prevention of disease, enable new and more precise diagnostic tests, and allow personalisation of drugs and other treatments to specific genetic variants.
Read more about the 1000th participant in the 100,000 genomes project on the CMFT website.